Free Trial

Inhibrx Biosciences (INBX) Competitors

Inhibrx Biosciences logo
$16.28 +0.55 (+3.46%)
Closing price 07/3/2025 01:04 PM Eastern
Extended Trading
$16.28 0.00 (0.00%)
As of 05:47 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

INBX vs. AVXL, COGT, CMRX, CDMO, AVBP, SNDX, IMNM, QURE, PHAR, and XERS

Should you be buying Inhibrx Biosciences stock or one of its competitors? The main competitors of Inhibrx Biosciences include Anavex Life Sciences (AVXL), Cogent Biosciences (COGT), Chimerix (CMRX), Avid Bioservices (CDMO), ArriVent BioPharma (AVBP), Syndax Pharmaceuticals (SNDX), Immunome (IMNM), uniQure (QURE), Pharming Group (PHAR), and Xeris Biopharma (XERS). These companies are all part of the "pharmaceutical products" industry.

Inhibrx Biosciences vs. Its Competitors

Inhibrx Biosciences (NASDAQ:INBX) and Anavex Life Sciences (NASDAQ:AVXL) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, earnings, media sentiment, profitability, valuation and dividends.

In the previous week, Anavex Life Sciences had 3 more articles in the media than Inhibrx Biosciences. MarketBeat recorded 4 mentions for Anavex Life Sciences and 1 mentions for Inhibrx Biosciences. Anavex Life Sciences' average media sentiment score of 0.45 beat Inhibrx Biosciences' score of 0.00 indicating that Anavex Life Sciences is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inhibrx Biosciences
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Anavex Life Sciences
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Anavex Life Sciences has a consensus target price of $44.00, suggesting a potential upside of 310.45%. Given Anavex Life Sciences' stronger consensus rating and higher possible upside, analysts clearly believe Anavex Life Sciences is more favorable than Inhibrx Biosciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inhibrx Biosciences
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Anavex Life Sciences
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33

Inhibrx Biosciences has a beta of -0.04, suggesting that its share price is 104% less volatile than the S&P 500. Comparatively, Anavex Life Sciences has a beta of 0.72, suggesting that its share price is 28% less volatile than the S&P 500.

82.5% of Inhibrx Biosciences shares are owned by institutional investors. Comparatively, 31.6% of Anavex Life Sciences shares are owned by institutional investors. 11.0% of Anavex Life Sciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Inhibrx Biosciences has higher revenue and earnings than Anavex Life Sciences. Anavex Life Sciences is trading at a lower price-to-earnings ratio than Inhibrx Biosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inhibrx Biosciences$200K1,179.03$1.69B$116.750.14
Anavex Life SciencesN/AN/A-$43M-$0.55-19.49

Anavex Life Sciences' return on equity of -40.93% beat Inhibrx Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Inhibrx BiosciencesN/A -85.12% -58.90%
Anavex Life Sciences N/A -40.93%-36.38%

Summary

Anavex Life Sciences beats Inhibrx Biosciences on 10 of the 15 factors compared between the two stocks.

Get Inhibrx Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for INBX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INBX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INBX vs. The Competition

MetricInhibrx BiosciencesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$235.81M$2.89B$5.53B$9.02B
Dividend YieldN/A2.44%5.22%3.99%
P/E Ratio0.1421.7127.7920.25
Price / Sales1,179.03283.26430.22119.26
Price / Cash0.1441.7026.2128.59
Price / Book1.767.538.035.65
Net Income$1.69B-$55.14M$3.18B$249.15M
7 Day Performance14.12%4.22%2.88%2.91%
1 Month Performance16.99%0.91%1.67%4.11%
1 Year Performance26.34%5.40%34.26%20.98%

Inhibrx Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INBX
Inhibrx Biosciences
0.9886 of 5 stars
$16.29
+3.5%
N/A+26.3%$235.81M$200K0.14166
AVXL
Anavex Life Sciences
3.602 of 5 stars
$9.22
-2.7%
$44.00
+377.2%
+155.8%$809.33MN/A-16.7640
COGT
Cogent Biosciences
2.5935 of 5 stars
$7.18
+1.1%
$14.43
+101.0%
-9.8%$808.38MN/A-3.9080
CMRX
Chimerix
0.6236 of 5 stars
$8.54
flat
$8.53
-0.1%
N/A$801.09M$212K-9.0990
CDMO
Avid Bioservices
0.6845 of 5 stars
$12.50
+0.1%
$12.25
-2.0%
+68.4%$799.18M$139.91M-5.23320High Trading Volume
AVBP
ArriVent BioPharma
1.7393 of 5 stars
$21.77
-5.0%
$40.00
+83.7%
+11.6%$783.81MN/A-5.7740
SNDX
Syndax Pharmaceuticals
3.1317 of 5 stars
$9.36
+3.5%
$35.80
+282.5%
-55.7%$777.87M$23.68M-2.42110
IMNM
Immunome
2.4409 of 5 stars
$9.30
+6.0%
$23.33
+150.9%
-27.6%$763.10M$9.04M-2.9240High Trading Volume
QURE
uniQure
2.1162 of 5 stars
$13.94
+0.6%
$37.82
+171.3%
+277.2%$759.19M$27.12M-3.18500
PHAR
Pharming Group
2.8968 of 5 stars
$10.68
-2.9%
$30.00
+181.0%
+27.7%$748.58M$297.20M-53.38280Gap Down
High Trading Volume
XERS
Xeris Biopharma
3.6293 of 5 stars
$4.67
-0.6%
$6.25
+33.8%
+125.4%$735.01M$222.55M-15.57290

Related Companies and Tools


This page (NASDAQ:INBX) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners